Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5180615
Max Phase: Preclinical
Molecular Formula: C21H24N4O
Molecular Weight: 348.45
Associated Items:
ID: ALA5180615
Max Phase: Preclinical
Molecular Formula: C21H24N4O
Molecular Weight: 348.45
Associated Items:
Canonical SMILES: Cc1nc2c(C(=O)N3CCCCC3)cnn2c(C)c1Cc1ccccc1
Standard InChI: InChI=1S/C21H24N4O/c1-15-18(13-17-9-5-3-6-10-17)16(2)25-20(23-15)19(14-22-25)21(26)24-11-7-4-8-12-24/h3,5-6,9-10,14H,4,7-8,11-13H2,1-2H3
Standard InChI Key: NNSYJQPRNMBKHX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 348.45 | Molecular Weight (Monoisotopic): 348.1950 | AlogP: 3.56 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.50 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.53 | CX LogP: 3.22 | CX LogD: 3.22 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.73 | Np Likeness Score: -1.73 |
1. Zhang G, Wang F, Li S, Cheng KW, Zhu Y, Huo R, Abdukirim E, Kang G, Chou TF.. (2022) Discovery of small-molecule inhibitors of RUVBL1/2 ATPase., 62 [PMID:35364523] [10.1016/j.bmc.2022.116726] |
Source(1):